Jyong Biotech Ltd.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -26.6% | -7.3% | -5.7% | -22.8% | +226.4% | |
| – | -57.4% | -7.0% | -25.3% | -88.8% | +7,444.7% | |
| – | -84.5% | +30.3% | -75.3% | -44.6% | +1,102.0% | |
| – | -43.5% | -66.0% | -78.2% | -44.6% | +1,102.0% | |
| – | – | – | – | – | – | |
| – | +2.2% | +17.2% | +10.3% | +1.3% | +6.5% | |
| – | +8.9% | +105.1% | +10.5% | -14.9% | +187.0% | |
| – | +4.6% | +50.8% | +3.6% | -8.2% | +12.4% | |
| – | +84.0% | -91.3% | -50.0% | +50.0% | -33.3% | |
| – | – | +0.9% | +34.9% | +25.3% | -4.9% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | +6.2% | +0.0% | +0.0% | +0.0% | -4.0% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.